Edition:
India

Pieris Pharmaceuticals Inc (PIRS.OQ)

PIRS.OQ on NASDAQ Stock Exchange Capital Market

5.82USD
11 Dec 2017
Change (% chg)

-- (--)
Prev Close
$5.82
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
84,882
52-wk High
$6.65
52-wk Low
$1.34

Select another date:

Thu, Dec 7 2017

BRIEF-Pieris Pharma Received Clearance to Initiate Its First-In-Human Study In Australia For PRS-060/AZD1402

* PIERIS PHARMACEUTICALS - RECEIVED ETHICS AND REGULATORY CLEARANCE TO INITIATE ITS FIRST-IN-HUMAN STUDY IN AUSTRALIA FOR PRS-060/AZD1402

BRIEF-Pieris Pharmaceuticals appoints James Geraghty as chairman of board of directors

* Pieris Pharmaceuticals appoints James Geraghty as chairman of the board of directors

BRIEF-Pieris Pharmaceuticals reports Q3 loss per share $0.16

* Pieris Pharmaceuticals reports financial results for the third quarter ended september 30, 2017, and provides corporate update

BRIEF-Pieris Pharmaceuticals names Allan Reine CFO

* Pieris Pharmaceuticals appoints Allan Reine, M.D., as chief financial officer Source text for Eikon: Further company coverage:

BRIEF-Sichuan Kelun Pharmaceutical unit signs license agreement with Pieris Pharmaceuticals

* Says its Sichuan-based unit signs license agreement with Pieris Pharmaceuticals Inc, regarding a patent of tumour immunotherapy

BRIEF-Pieris Pharmaceuticals Q2 loss per share $0.23

* Pieris Pharmaceuticals reports financial results for the second quarter ended June 30, 2017 and provides corporate update

BRIEF-Pieris Pharma announces results from 2017 annual meeting of stockholders

* Pieris Pharmaceuticals announces results from 2017 annual meeting of stockholders and provides update on therapeutic programs

Select another date: